All Terrain Financial Advisors’s Gilead Sciences GILD Stock Holding History

All Terrain Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-600	Closed	-$45K	–	123
2020 Q1	$45K	Hold	600	–	–	0.02%	167
2019 Q4	$39K	Hold	600	–	–	0.01%	203
2019 Q3	$38K	Hold	600	–	–	0.01%	203
2019 Q2	$41K	Hold	600	–	–	0.01%	195
2019 Q1	$39K	Sell	600 -600	-50%	-$39.9K	0.01%	222
2018 Q4	$75K	Buy	1,200 +500	+71%	+$34.9K	0.03%	173
2018 Q3	$54K	Sell	700 -600	-46%	-$45.3K	0.02%	210
2018 Q2	$92K	Buy	1,300 +100	+8%	+$7.06K	0.04%	199
2018 Q1	$90K	Buy	+1,200	New	+$95.4K	0.04%	198

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

All Terrain Financial Advisors's GILD Position: Q2 2020 in Review

All Terrain Financial Advisors sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 3,300 shares — an estimated $247K sold.

All Terrain Financial Advisors first reported a position in GILD in Q4 2017 and held it in 10 quarters. The position peaked at $523K in Q2 2018. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

All Terrain Financial Advisors reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
All Terrain Financial Advisors sold 3,300 Gilead Sciences shares in Q2 2020, an estimated $247K.
All Terrain Financial Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 10 quarters.
All Terrain Financial Advisors's Gilead Sciences position peaked at $523K in Q2 2018.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on All Terrain Financial Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.